FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4250208580> ?p ?o ?g. }

• W4250208580 endingPage "13" @default.
• W4250208580 startingPage "12" @default.
• W4250208580 abstract "Drs Harris, Raistrick and Teesson raise important considerations about the integration of treatments for substance use disorders (SUD) into general medical settings. Recently enacted US legislation has the potential to transform interventions for drug use disorders 1, 2 and standardized and validated screening for SUD must be a part of electronic health records (EHR) 3. Development of the EHR recommendations was needed—and needed urgently—if substance abusing patients are to be adequately served by medical practitioners 4. Each of the commentaries points out important, yet challenging, issues that must be considered before implementing SUD standardized data collection, associated screening and brief intervention (SBI), and clinical quality measures on a large scale. Maree Teesson cautions that the stigma of SUD, and the underfunding and poor coordination of treatment, will continue to hinder integration into general medical care 5. Including SUD in EHR will only achieve its potential of improved access, safety and effectiveness of care when it is implemented in combination with clinical decision support and other needed improvements to care and the shift of certain SUD services to the general medical setting. For example, we would expect the stigma of SUD to dissipate with time once an increased number of patients are identified and treated in general medical settings. Confidentiality concerning drug treatment is already protected by US federal law and will be protected by built-in safeguards for trusted exchange of information in EHRs. Duncan Raistrick points out the limitations of expert groups and favors a systematic literature review 6. We do not fundamentally disagree, but believe there are sufficient systematic reviews already available—some of which were cited in the commentaries and were reviewed by our taskforce. While we recognize the utility and convenience of a package of measures, particularly for drug, alcohol and tobacco use, our taskforce was constrained in scope to drug use. We concur with Raistrick that validation of the proposed instruments is limited and expect further validation or alternatives to be identified as ongoing validation occurs and the science evolves. Alex Harris notes the paucity of scientific evidence for screening and effectiveness of brief treatments for drug use disorder in general medical care 7. We agree that empirically-demonstrated benefits are needed before wide implementation. Our article noted that pilot testing of these common data elements and accompanying clinical decision support in Screening, Brief Intervention and Referral to Treatment (SBIRT) within a Substance Abuse and Mental Health Services Administration (SAMHSA) EHR is being planned, and the results of that study, and others, are expected to add to published evidence needed to satisfy the Centers for Medicare and Medicaid Services EHR Meaningful Use criteria. Identifying suitable data elements is only a first step. Our article was intended to continue and broaden the stakeholder feedback we have sought throughout the consensus-building process and we appreciate these very thoughtful comments. Several authors are employees of the Center for the Clinical Trials Network of the National Institute on Drug Abuse, National Institutes of Health, the funding agency for the National Drug Abuse Treatment Clinical Trials Network. The opinions in this manuscript are those of the authors and do not represent the official position of the US Government." @default.
• W4250208580 created "2022-05-12" @default.
• W4250208580 creator A5000565361 @default.
• W4250208580 creator A5009057770 @default.
• W4250208580 creator A5020105118 @default.
• W4250208580 creator A5048600560 @default.
• W4250208580 creator A5075470455 @default.
• W4250208580 creator A5084946990 @default.
• W4250208580 date "2012-12-26" @default.
• W4250208580 modified "2023-09-24" @default.
• W4250208580 title "Response to commentaries" @default.
• W4250208580 cites W1982028612 @default.
• W4250208580 cites W2005222471 @default.
• W4250208580 cites W2027595299 @default.
• W4250208580 cites W2042975668 @default.
• W4250208580 cites W2061254107 @default.
• W4250208580 cites W2116591230 @default.
• W4250208580 cites W2130778649 @default.
• W4250208580 doi "https://doi.org/10.1111/j.1360-0443.2012.03979.x" @default.
• W4250208580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23279355" @default.
• W4250208580 hasPublicationYear "2012" @default.
• W4250208580 type Work @default.
• W4250208580 citedByCount "0" @default.
• W4250208580 crossrefType "journal-article" @default.
• W4250208580 hasAuthorship W4250208580A5000565361 @default.
• W4250208580 hasAuthorship W4250208580A5009057770 @default.
• W4250208580 hasAuthorship W4250208580A5020105118 @default.
• W4250208580 hasAuthorship W4250208580A5048600560 @default.
• W4250208580 hasAuthorship W4250208580A5075470455 @default.
• W4250208580 hasAuthorship W4250208580A5084946990 @default.
• W4250208580 hasBestOaLocation W42502085801 @default.
• W4250208580 hasConcept C118552586 @default.
• W4250208580 hasConcept C126838900 @default.
• W4250208580 hasConcept C159110408 @default.
• W4250208580 hasConcept C160735492 @default.
• W4250208580 hasConcept C168285401 @default.
• W4250208580 hasConcept C17744445 @default.
• W4250208580 hasConcept C195910791 @default.
• W4250208580 hasConcept C199539241 @default.
• W4250208580 hasConcept C27415008 @default.
• W4250208580 hasConcept C2777351106 @default.
• W4250208580 hasConcept C2780665704 @default.
• W4250208580 hasConcept C40010229 @default.
• W4250208580 hasConcept C512399662 @default.
• W4250208580 hasConcept C545542383 @default.
• W4250208580 hasConcept C71745522 @default.
• W4250208580 hasConcept C71924100 @default.
• W4250208580 hasConceptScore W4250208580C118552586 @default.
• W4250208580 hasConceptScore W4250208580C126838900 @default.
• W4250208580 hasConceptScore W4250208580C159110408 @default.
• W4250208580 hasConceptScore W4250208580C160735492 @default.
• W4250208580 hasConceptScore W4250208580C168285401 @default.
• W4250208580 hasConceptScore W4250208580C17744445 @default.
• W4250208580 hasConceptScore W4250208580C195910791 @default.
• W4250208580 hasConceptScore W4250208580C199539241 @default.
• W4250208580 hasConceptScore W4250208580C27415008 @default.
• W4250208580 hasConceptScore W4250208580C2777351106 @default.
• W4250208580 hasConceptScore W4250208580C2780665704 @default.
• W4250208580 hasConceptScore W4250208580C40010229 @default.
• W4250208580 hasConceptScore W4250208580C512399662 @default.
• W4250208580 hasConceptScore W4250208580C545542383 @default.
• W4250208580 hasConceptScore W4250208580C71745522 @default.
• W4250208580 hasConceptScore W4250208580C71924100 @default.
• W4250208580 hasIssue "1" @default.
• W4250208580 hasLocation W42502085801 @default.
• W4250208580 hasLocation W42502085802 @default.
• W4250208580 hasOpenAccess W4250208580 @default.
• W4250208580 hasPrimaryLocation W42502085801 @default.
• W4250208580 hasRelatedWork W1487091914 @default.
• W4250208580 hasRelatedWork W2178820019 @default.
• W4250208580 hasRelatedWork W2342856937 @default.
• W4250208580 hasRelatedWork W2389797584 @default.
• W4250208580 hasRelatedWork W2406987650 @default.
• W4250208580 hasRelatedWork W3003183486 @default.
• W4250208580 hasRelatedWork W3111307622 @default.
• W4250208580 hasRelatedWork W3185205286 @default.
• W4250208580 hasRelatedWork W4236944649 @default.
• W4250208580 hasRelatedWork W4294085544 @default.
• W4250208580 hasVolume "108" @default.
• W4250208580 isParatext "false" @default.
• W4250208580 isRetracted "false" @default.
• W4250208580 workType "article" @default.